Abstract
The p53 network is perhaps the most important pathway involved in preventing the initiation of cancer. p53 levels and activity are upregulated in response to various, stresses including DNA damage, hypoxia, and oncogene activation. Active p53 initiates different transcriptional programs that result in cell cycle arrest, cellular senescence or apoptosis. p53 also activates the transcription of Mdm2, which in turns target p53 for degradation, therefore creating a negative feedback loop on p53. Previous studies showed that the level of p53 increased dramatically after exposure to damaging radiation, then declined in a series of damped oscillations. Recent quantitative studies examined p53 responses in individual living cells, using time-lapse fluorescent microscopy and showed that—on an individual cell level—the oscillations are not damped. Instead one cell may have only one pulse of p53, while its neighbor may show several repeated pulses. As the amount of irradiation increased, the percentage of cells showing a high number of p53 pulses also increased. The mean height and width of the pulses was constant and did not depend on the damage level. These observations opened new questions regarding the mechanism and function of p53 oscillatory dynamics. In this chapter I will review the different models that have been suggested for p53 oscillations, including proposed reasons for variation between cells, and will discuss potential functions for oscillatory dynamics in the p53 signaling pathway and in stress responses in general.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997; 88(3):323–331.
Jin S, Levine AJ. The p53 functional circuit. J Cell Sci 2001; 114(Pt 23): 4139–4140.
Vogelstein B, Lane D, Levine AJ. Surfing the p53 network. Nature 2000; 408(6810):307–310.
Hofseth LJ, Hussain SP, Harris CC. p53: 25 years after its discovery. Trends Pharmacol Sci 2004; 25(4):177–181.
Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421(6922):499–506.
Barak Y, Juven T, Haffner, R et al. Mdm2 expression is induced by wild type p53 activity. EMBO J 1993; 12(2):461–468.
Wu X, Bayle JH, Olson D et al. The p53-mdm-2 autoregulatory feedback loop. Genes Dev 1993; 7(7A):1126–1132.
Haupt Y, Maya R, Kazaz A et al. Mdm2 promotes the rapid degradation of p53. Nature 1997; 387(6630):296–299.
Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature 1997; 387(6630):299–303.
Michael D, Oren M. The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 2003; 13(1):49–58.
Harris SL, Levine AJ. The p53 pathway: Positive and negative feedback loops. Oncogene 2005; 24(17):2899–2908.
Dornan D, Wertz I, Shimizu H et al. The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 2004; 429(6987):86–92.
Leng RP, Lin Y, Ma W et al. Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 2003; 112(6):779–791.
Yeger-Lotem E, Sattath S, Kashtan N et al. Network motifs in integrated cellular networks of transcription-regulation and protein-protein interaction. Proc Natl Acad Sci USA 2004; 101(16):5934–5939.
Tyson JJ. Monitoring p53’s pulse. Nat Genet 2004; 36(2):113–114.
Tyson JJ, Chen KC, Novak B. Sniffers, buzzers, toggles and blinkers: Dynamics of regulatory and signaling pathways in the cell. Curr Opin Cell Biol 2003; 15(2):221–231.
Nelson DE, Ihekwaba AEC, Elliott M et al. Oscillations in NF-{kappa} B signaling control the dynamics of gene expression. Science 2004; 306(5696):704–708.
Hoffmann A, Levchenko A, Scott ML et al. The IkB-NF-kB signaling module: Temporal control and selective gene activation. Science 2002; 298:1241–1245.
Lev Bar-Or R, Maya R, Segel LA et al. Generation of oscillations by the p53-Mdm2 feedback loop: A theoretical and experimental study. Proc Natl Acad Sci USA 2000; 97(21):11250–11255.
Lahav G, Rosenfeld N, Sigal A et al. Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat Genet 2004; 36(2):147–150.
Tyson JJ. Another turn for p53. Mol Syst Biol 2006; 2:0032.
Hamstra DA, Bhojani MS, Griffin LB et al. Real-time evaluation of p53 oscillatory behavior in vivo using bioluminescent imaging. Cancer Res 2006; 66(15):7482–7489.
Mihalas GI, Simon Z, Balea G et al. Possible oscillatory behavior in p53-Mdm2 interaction computer simulation. Journal of Biological Systems 2000; 8:21–29.
Monk NAM. Oscillatory expression of Hes1, p53, and NF-κB driven by transcriptional time delays. Curr Biol 2003; 13(16):1409–1413.
Tiana G, Jensen MH, Sneppen K. Time delay is a key to apoptosis induction in the p53 network. European Physical Journal B 2002; 29:135–140.
Ma L, Wagner J, Rice JJ et al. A plausible model for the digital response of p53 to DNA damage. Proc Natl Acad Sci USA 2005; 102(40):14266–14271.
Wagner J, Ma L, Rice JJ et al. p53-Mdm2 loop controlled by a balance of its feedback strength and effective dampening using ATM and delayed feedback. IEEE Proc.-Syst Biol 2005; 152(3):109–118.
Ciliberto A, Novak B, Tyson JJ. Steady states and oscillations in the p53/Mdm2 network. Cell Cycle 2005; 4(3):488–493.
Pomerening JR, Kim SY, Ferrell Jr JE. Systems-level dissection of the cell-cycle oscillator: Bypassing positive feedback produces damped oscillations. Cell 2005; 122(4):565–578.
Mayo LD, Dixon JE, Durden DL et al. PTEN protects p53 from Mdm2 and sensitizes cancer cells to chemotherapy. J Biol Chem 2002; 277(7):5484–5489.
Martoriati A, Doumont G, Alcalay M et al. dapk1, encoding an activator of a p19ARF-p53-mediated apoptotic checkpoint, is a transcription target of p53. Oncogene 2005; 24(8):1461–1466.
Deguin-Chambon V, Vacher M, Jullien M et al. Direct transactivation of c-Ha-Ras gene by p53 Evidence for its involvement in p53 transactivation activity and p53-mediated apoptosis. Oncogene 2000; 19(51):5831–5841.
Ongusaha PP, Kim JI, Fang L et al. p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop. EMBO J 2003; 22(6):1289–1301.
Geva-Zatorsky N, Rosenfeld N, Itzkovitz S et al. Oscillations and variability in the p53 system. Molecular Systems Biology 2006; 2:E1–E13.
Camman CE, Lim DS, Gimprich KA et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998; 281(5383):1677–1679.
Canman CE, Lim DS. The role of ATM in DNA damage responses and cancer. Oncogene 1998; 17(25):3301–3308.
Khosravi R, Maya R, Gottlieb T et al. Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage. Proc Natl Acad Sci USA 1999; 96(26):14973–14977.
Okamoto K, Kamibayashi C, Serrano M et al. p53-dependent association between cyclin G and the B’ subunit of protein phosphatase 2A. Mol Cell Biol 1996; 16(11):6593–6602.
Ohtsuka T, Jensen MR, Kim HG, et al. The negative role of cyclin G in ATM-dependent p53 activation. Oncogene 2004; 23(31):5405–5408.
Goodarzi AA, Jonnalagadda JC, Douglas P et al. Autophosphorylation of ataxia-telangiectasia mutated is regulated by protein phosphatase 2A. EMBO J 2004; 23(22):4451–4461.
Reimer CL, Borras AM, Kurdistani SK et al. Altered regulation of cyclin G in human breast cancer and its specific localization at replication foci in response to DNA damage in p53+/+ cells. J Biol Chem 1999; 274(16):11022–11029.
Fiscella M, Zhang H, Fan S et al. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc Natl Acad Sci USA 1997; 94(12):6048–6053.
Lu X, Nannenga B, Donehower LA. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev 2005; 19(10):1162–1174.
Fujimoto H, Onishi N, Kato N et al. Regulation of the antioncogenic Chk2 kinase by the oncogenic Wip1 phosphatase. Cell Death Differ 2005.
Rothkamm K, Lobrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low X-ray doses. Proc Natl Acad Sci USA 2003; 100(9):5057–5062.
Lahav G. The strength of indecisiveness: Oscillatory behavior for better cell fate determination. Sci STKE 2004; 2004(264):pe55.
Komiyama S, Taniguchi S, Matsumoto Y et al. Potentiality of DNA-dependent protein kinase to phosphorylate Ser46 of human p53. Biochem Biophys Res Commun 2004; 323(3):816–822.
Oda K, Arakawa H, Tanaka T et al. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 2000; 102(6):849–862.
Mayo LD, Seo YR, Jackson MW et al. Phosphorylation of human p53 at serine 46 determines promoter selection and whether apoptosis is attenuated or amplified. J Biol Chem 2005; 280(28):25953–25959.
Nelson DE, See V, Nelson G et al. Oscillations in transcription factor dynamics: A new way to control gene expression. Biochem Soc Trans 2004; 32(Pt 6):1090–1092.
Friedman N, Vardi S, Ronen M et al. Precise temporal modulation in the response of the SOS DNA repair network in individual bacteria. PLoS Biol 2005; 3(7):e238.
Bond GL, Hu W, Bond EE et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 2004; 119(5):591–602.
Bond GL, Hu W, Levine A. A single nucleotide polymorphism in the MDM2 gene: From a molecular and cellular explanation to clinical effect. Cancer Res 2005; 65(13):5481–5484.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Landes Bioscience and Springer Science+Business Media
About this chapter
Cite this chapter
Lahav, G. (2008). Oscillations by the p53-Mdm2 Feedback Loop. In: Maroto, M., Monk, N.A.M. (eds) Cellular Oscillatory Mechanisms. Advances in Experimental Medicine and Biology, vol 641. Springer, New York, NY. https://doi.org/10.1007/978-0-387-09794-7_2
Download citation
DOI: https://doi.org/10.1007/978-0-387-09794-7_2
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-09793-0
Online ISBN: 978-0-387-09794-7
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)